Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung CancerPei‐Chih Lee, Mien‐Chie Hung, Tse-Ching Chen et al.|Cancer Cell|2018Cited by 71
Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removalXiaoxin Hao, Xiang H.-F. Zhang, Yichao Shen et al.|Cell stem cell|2023Cited by 59